The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.
April 4th 2025
In a study recently presented at the American College of Cardiology (ACC) conference, researchers found that novice use of AI-guided cardiac ultrasound after an AI-enabled electrocardiogram increased the positive predictive value for reduced left ventricular ejection fraction (LVEF) or aortic valve stenosis by 33 percent.
Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment
April 4, 2025 | New York, NY & Virtual
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
Microbubble-based scans reach beyond liver
February 15th 2008Ultrasound is the most commonly used abdominal imaging modality. The addition of color and spectral Doppler imaging has been particularly beneficial. When ultrasound findings are nonspecific, however, patients are generally referred to CT or MRI
Echocardiography society issues new guidelines for carotid ultrasound
February 11th 2008The American Society of Echocardiography has issued a new consensus statement for interpreting and responding to results of carotid artery ultrasound. The guidelines set carotid artery wall thickness values greater than the 75th percentile as the threshold for aggressive treatment.
Ultrasound matches MRI and gold standard tests in detecting extent of Crohn’s disease
February 11th 2008Color Doppler flow and sonographic wall thickness are as good as -- and in some cases better than -- contrast MRI for showing the extent of Crohn’s disease. Both ultrasound and MRI match clinical results from barium studies, surgery, and colonoscopy.
Screening tackles hidden cardiovascular disease in retired football pros
February 7th 2008The colossal linemen of the National Football League and large folks in general may have more in common than their size. Everyone who weighs more than 300 pounds is more than twice as likely as a lighter person to die from a heart attack or stroke, according to a study sponsored by the Living Heart Foundation.
High-quality ultrasound demonstrates measureable effect in ovarian cancer management
February 4th 2008Ultrasound exams conducted by expert sonographers make a measurable difference over routine exams in the treatment of suspected ovarian cancer, decreasing the number of major staging procedures and reducing in-patient hospital stays.
Breast ultrasound adjusts to get past false positives
January 10th 2008The massive American College of Radiology Imaging Network 6666 trial shows that adding ultrasound to the initial breast screening protocol for high-risk women could help detect 30% more cancers, but at the questionable cost of many more needless biopsies of benign lesions.
Lack of national diagnosis, care plan spurs call for action
January 10th 2008Prostate cancer imaging experts sent out a clear message in 2007: Prostate cancer in the U.S. has become an unrecognized patient care crisis that needs tackling. The good news is these experts agree that advanced imaging technologies could help in early detection and minimally invasive treatment. The lack of a cohesive national strategy is worrisome, however, and they want to see the adoption of a broad initiative for diagnosing and treating prostate cancer similar to that for breast cancer.
MR elastography proves edge in liver fibrosis staging
January 10th 2008Researchers in Belgium have found that MR elastography is more accurate than a blood test commonly used in the noninvasive staging of liver fibrosis. The study adds weight to clinical literature that suggests MR elastography could replace biopsy.
FDA warning flummoxes ultrasound contrast trial
January 10th 2008Plans for a clinical trial designed to overcome long-standing regulatory obstacles to the general clinical use of ultrasound contrast media in the U.S. have been knocked off track by an FDA-mandated black box safety warning for two microbubble agents approved for echocardiography.
Fractures and liver lesions top list of residents' ER misses
January 10th 2008Researchers used a customized search engine to quickly find that most discordant resident versus attending physician preliminary reports involved fractures, liver/kidney lesions, pulmonary nodules, and gastrointestinal wall thickening.
Breast MR imaging aids high-risk women
January 10th 2008A large prospective screening trial from the University of Pennsylvania compared screen-film mammography, digital mammography, whole-breast ultrasound, and contrast-enhanced MRI in a population of 569 asymptomatic women. In this single-center trial, funded by the National Cancer Institute, the definition of high risk included women with a 25% lifetime risk based on genetic testing or Gail or Claus models and those with a history of cancer in the contralateral breast.